{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:10:26Z","timestamp":1771326626910,"version":"3.50.1"},"reference-count":39,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Reports"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Backgrounds<\/jats:title>\n                    <jats:p>Gastric adenocarcinoma is a common and severe type of malignancy. Treatment for advanced cases involves neoadjuvant chemotherapy before surgery and adjuvant chemotherapy if needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>In this study, a comparison of two regimens of FLOT and mDCF has been conducted with regard to pathological and radiological response, as well as complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and Results<\/jats:title>\n                    <jats:p>The medical records of patients diagnosed with nonmetastatic gastric adenocarcinoma who randomly received therapy with either FLOT or mDCF regimens were studied. The two groups were compared regarding complications, radiological response based on RECIST Ver 1.1 criteria, the chance of successful gastrectomy, pathological response based on the TRG scale, and downstaging of the gastric adenocarcinoma following chemotherapy. In total, 90 patients were studied. 40 patients were treated with the mDCF regimen, while 50 received the FLOT regimen. The mDCF group experienced more side effects, and the FLOT group had higher response rates and a greater percentage of patients who underwent surgery with clear margins. Additionally, patients receiving FLOT treatment showed greater lymphatic involvement, tissue invasion, and disease stage improvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>According to the study, patients with limited local invasion gastric adenocarcinoma who are eligible for surgery may benefit more from the FLOT neoadjuvant regimen than the mDCF regimen. The FLOT regimen proves to be more efficient and has fewer complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/cnr2.70247","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T23:43:59Z","timestamp":1748907839000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of Neoadjuvant Chemotherapy With\n                    <scp>FLOT<\/scp>\n                    and Modified\n                    <scp>DCF<\/scp>\n                    Regimens in Nonmetastatic Gastric Adenocarcinoma"],"prefix":"10.1002","volume":"8","author":[{"given":"Mehdi","family":"Pourghasemian","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Hematology and Oncology Division School of Medicine, Ardabil University of Medical Sciences  Ardabil Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Salimi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine School of Medicine, Ardabil University of Medical Sciences  Ardabil Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Effat","family":"Iranijam","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hematology and Oncology Division School of Medicine, Ardabil University of Medical Sciences  Ardabil Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8293-9139","authenticated-orcid":false,"given":"Mohammad","family":"Negaresh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine School of Medicine, Ardabil University of Medical Sciences  Ardabil Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"issue":"7","key":"e_1_2_11_2_1","first-page":"3277","article-title":"Oxaliplatin, 5fluorouracil and Leucovorin (FOLFOX4) as First Line Chemotherapy in Elderly Patients With Advanced Gastric Cancer","volume":"17","author":"Haghighi S.","year":"2016","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2021.1168"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2013.1449"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2018.01.008"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.0735"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.7314\/APJCP.2014.15.9.3945"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30354-3"},{"key":"e_1_2_11_9_1","doi-asserted-by":"crossref","unstructured":"P.RawlaandA.Barsouk \u201cEpidemiology of Gastric Cancer: Global Trends Risk Factors and Prevention. Przeglad Gastroenterologiczny \u201d14 no.1(2019):26\u201338. Epub 2019\/04\/05 https:\/\/doi.org\/10.5114\/pg.2018.80001. PubMed PMID: 30944675; PubMed Central PMCID: PMCPMC6444111.","DOI":"10.5114\/pg.2018.80001"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.9.1318"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21339"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055531"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2007.25.18_suppl.4510"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25064"},{"issue":"8","key":"e_1_2_11_15_1","article-title":"Chemotherapy for Advanced Gastric Cancer","volume":"8","author":"Wagner A. D.","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1159\/000328746"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-010-1353-6"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70035-4"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.10.4968"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S200883"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-019-0393-7"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12876\u2010017\u20100598\u20105"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C"},{"key":"e_1_2_11_25_1","unstructured":"Institute NC Common Terminology Criteria for Adverse Events (CTCAE) accessed April 5 2020 https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm."},{"key":"e_1_2_11_26_1","unstructured":"Institute NC Common Toxicity Criteria (CTC) accessed April 5 2020 https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcv20_4\u201030\u2010992.pdf."},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2024.100845"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.4103\/1735\u20105362.359430"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10120\u2010015\u20100457\u20104"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1702823"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470\u20102045(16)30531\u20109"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2023.1148984"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29403"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467\u2010020\u201019965\u20106"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9189"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh134"},{"issue":"7","key":"e_1_2_11_37_1","first-page":"911","article-title":"Gan to Kagaku Ryoho","volume":"33","author":"Mishima H.","year":"2006","journal-title":"Cancer & Chemotherapy"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2013.31.4_suppl.138"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107061"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2021.05.006"}],"container-title":["Cancer Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cnr2.70247","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cnr2.70247","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cnr2.70247","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T10:14:29Z","timestamp":1771323269000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cnr2.70247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1002\/cnr2.70247"],"URL":"https:\/\/doi.org\/10.1002\/cnr2.70247","archive":["Portico"],"relation":{},"ISSN":["2573-8348","2573-8348"],"issn-type":[{"value":"2573-8348","type":"print"},{"value":"2573-8348","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"2024-05-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70247"}}